What Should Labs Check Before Buying IVD Calibrators?
Reliable calibration begins long before a vial is placed on an analyzer. Laboratories need to confirm that a product is suitable for the intended assay, measurement interval, specimen type and instrument configuration. They must also understand how assigned values were established, how the material should be stored and whether the documentation supports controlled use. Treating these factors as a connected purchasing decision helps protect result accuracy and operational continuity.
The evaluation should extend beyond price and pack size. IVD calibrators influence the reference points used to calculate patient results, so an unsuitable or poorly documented material may introduce systematic error across an entire run. A structured review covering analytical compatibility, traceability, stability, regulatory status, supplier performance and acceptance testing enables laboratories to select products that fit both their technical procedures and quality system.
Why Is Careful Calibrator Selection Important for Laboratories?
A calibrator establishes one or more reference points that a test system uses when determining values in human specimens, as reflected in the US regulatory definition of a calibrator. Its role differs from that of a control material: calibration defines or adjusts the measurement relationship, while quality control is generally used to monitor whether the established process continues to perform as expected. Confusing these functions can leave an analytical system inadequately assessed.
Selection therefore affects more than a single analytical run. Matrix effects, value assignment, commutability, handling requirements or instrument incompatibility can shift results even when the laboratory follows its routine procedure correctly. Suitable laboratory calibrators should support the claimed measurement procedure, concentration range and clinical application. Procurement staff, laboratory specialists and quality personnel should agree on these requirements before comparing offers or approving a substitute.
Does the IVD Calibrator Match the Intended Assay and Instrument?
Compatibility should be confirmed against the complete measurement system rather than inferred from a shared analyte name. The laboratory should compare the calibrator’s intended use with the assay methodology, reagent generation, analyzer model, software version, units, specimen matrix and calibration protocol. It should also verify whether the product is designed for quantitative, qualitative or semi-quantitative use and whether it supports the laboratory’s reportable interval.
The manufacturer’s instructions for use and the instrument documentation should provide the primary evidence. If the material is not named or permitted within the validated system, the laboratory should request written compatibility information and determine whether local verification or validation is required. A verbal statement from a distributor is not an adequate substitute for controlled technical documentation, particularly when a third-party or alternative product is being considered.
Analyte, Method and Measurement Range Compatibility
The analyte form, matrix, concentration levels and assigned units should align with the assay’s measurement principle and calibration model. Laboratories should confirm that the supplied levels adequately cover clinically relevant decision points and the working range. A material formulated for one method may behave differently in another, even when both systems report the same analyte.
Instrument-Specific and Third-Party Calibrator Requirements
Instrument-specific products usually come with clearly defined application parameters, whereas third-party materials may require additional configuration and documented verification. Before substitution, the laboratory should assess manufacturer restrictions, calibration frequency, curve format, barcode or value-entry requirements and any effect on warranties, regulatory claims or the validated status of the overall test system.
How Should Labs Evaluate Calibrator Traceability and Assigned Values?
Assigned values should be supported by a documented calibration hierarchy showing how the result connects to the highest available reference system component. ISO 17511:2020 specifies technical and documentation requirements for metrological traceability of values assigned to calibrators, trueness control materials and human samples. The laboratory should determine which reference material, reference measurement procedure or international conventional standard anchors the stated value.
This review is especially important when results must remain comparable across instruments, locations or time periods. Strong calibrator traceability documentation identifies the measurand, value-assignment procedure, measurement uncertainty and relevant reference system without overstating what can be traced. If no higher-order reference exists, the supplier should clearly describe the applicable conventional hierarchy and its limitations rather than presenting a vague claim of standardization.
Reference Standards and Metrological Traceability
The traceability statement should name the applicable certified reference material, reference measurement procedure or recognized conventional standard whenever one is available. Laboratories should check whether the hierarchy applies to the exact measurand and matrix used in their procedure. Traceability to an unrelated standard does not establish comparability for the intended clinical measurement.
Certificates, Uncertainty Data and Lot-Specific Values
Each lot should have accessible assigned values, units and supporting documentation. Where relevant, the certificate should explain uncertainty, value-assignment methods and any instrument- or method-specific targets. Laboratories should also verify that the vial, certificate, electronic value sheet and barcode data all refer to the same lot before those values are entered into the analyzer.
What Stability and Storage Conditions Should Be Checked?
Stability claims determine whether a product remains suitable throughout transport, storage and routine use. Before ordering, laboratories should review the unopened shelf life, minimum remaining shelf life at delivery, storage temperature, light sensitivity, humidity restrictions and allowable transport excursions. For products shipped cold or frozen, the order specification should also define the required shipping range and the evidence supplied to demonstrate that conditions were maintained.
Usable life after opening or reconstitution can be more important than the printed expiry date. A large pack may appear economical but create avoidable waste if the material expires shortly after opening or cannot withstand repeated freeze-thaw cycles. Estimated test volume, calibration frequency, vial size and backup stock should therefore be considered together. These details allow the laboratory to compare cost per usable calibration rather than cost per vial.
Shelf Life, Open-Vial Stability and Reconstitution
The laboratory should document expiry dating, open-vial stability, reconstitution fluid, mixing technique, equilibration time and the permitted number of freeze-thaw cycles. It should also confirm whether reconstituted material can be aliquoted and which containers are acceptable. Small deviations in volume or timing may alter concentrations and compromise the assigned values.
Temperature Control and Cold Chain Requirements
Shipping specifications should define acceptable temperatures, monitoring methods and the response to an excursion. On arrival, staff should review temperature evidence when required, inspect coolant and packaging condition, and quarantine questionable shipments. The laboratory should not assume that intact external packaging proves the material remained within its validated environmental limits during transit.
Which Quality and Regulatory Documents Should the Supplier Provide?
Documentation should establish what the product is, how it is intended to be used and whether it may lawfully be supplied in the destination market. The required evidence varies by jurisdiction and device status. In the European Union, Regulation (EU) 2017/746 includes requirements relating to information supplied with IVD devices and metrological traceability. In the United States, calibrators used for medical purposes fall within the device framework described in 21 CFR 862.1150.
Laboratories should translate applicable requirements into a document checklist rather than accepting a generic compliance statement. Depending on the market and product, the file may include instructions for use, certificates of analysis, traceability statements, safety data, labeling, declarations, registration or listing information, import documentation and evidence of the manufacturer’s quality system. All documents should match the ordered catalogue number, lot and intended use.
Instructions for Use, Certificates and Safety Documentation
The current instructions for use should describe intended purpose, composition, preparation, storage, limitations, warnings and performance-related handling. Lot-specific certificates should be legible and readily retrievable, while safety documentation should support appropriate handling and disposal. Revision numbers and effective dates help the laboratory prevent uncontrolled or outdated instructions from entering routine use.
Regulatory Status and Quality Management Evidence
Regulatory evidence should be checked for the destination country, not assumed from availability in another market. The laboratory should verify the manufacturer, authorized representative or importer where applicable, product identity and claimed status. Quality certificates should be current, issued by an appropriate body and relevant to the manufacturing activities associated with the supplied material.
How Can Labs Assess Lot Consistency and Supply Continuity?
Changing lots can alter assigned values, calibration response or material behavior, so laboratories should ask how the manufacturer controls between-lot consistency and communicates value changes. Useful information includes lot release criteria, availability of lot-specific documents, advance notice of transitions and the possibility of obtaining the incoming lot before the current lot is exhausted. This enables side-by-side assessment and reduces rushed implementation.
Supply planning should also reflect lead times, manufacturing schedules, import requirements, minimum order quantities and realistic expiry at delivery. For diagnostic laboratory procurement, continuity does not mean accumulating excessive stock; it means matching inventory to consumption while preserving enough time for receipt checks and lot verification. Laboratories may also define an approved contingency source, provided any alternative material undergoes the required technical review before use.
What Should Be Reviewed When Comparing Suppliers?
The supplier assessment should combine product suitability with evidence that orders can be fulfilled under controlled conditions. The laboratory should examine authorization within the distribution chain, storage and transport capabilities, document responsiveness, recall communication, complaint history and delivery performance. Quotation details should clearly identify catalogue numbers, pack configuration, temperature requirements, remaining shelf life and any accessories or diluents required for use.
Price comparisons are meaningful only when offers describe equivalent technical and service conditions. An IVD calibrator supplier that provides prompt lot documents, controlled shipping records and qualified technical support may reduce hidden costs caused by quarantine, rejected deliveries or delayed testing. Evaluation criteria should be defined in advance, applied consistently and retained as part of the laboratory’s approved-supplier process.
Technical Support and Complaint Handling
Technical support should be able to address assay compatibility, value assignment, excursions and unexpected calibration performance with documented responses. Laboratories should ask how complaints are logged, investigated and escalated, and how field safety notices or recalls are communicated. Clear contacts and response times are particularly important when calibration failure could interrupt essential testing.
Delivery Reliability and Traceable Distribution
The distribution path should preserve product identity, lot visibility and required environmental conditions from dispatch to receipt. Buyers should review shipment tracking, temperature-control capability, contingency arrangements and proof of authorized sourcing. Lot numbers and expiry dates on delivery documents should correspond with the physical products to support rapid reconciliation and recall action.
How Should Calibration Materials Be Verified After Delivery?
Every shipment should undergo documented receipt checks before release to routine use. Staff should confirm the product and catalogue number, lot, quantity, expiry, packaging integrity and transport condition, then compare accompanying records with the purchase specification. Any damage, missing certificate, labeling mismatch or temperature concern should trigger quarantine and supplier investigation rather than immediate placement into active inventory.
New lots or replacement materials should then be assessed under the laboratory’s approved procedure before patient testing depends on them. The scope may include comparison with the current lot, calibration acceptance, quality-control review and evaluation at medically important concentrations, depending on the measurement procedure and local requirements. The WHO Laboratory Quality Stepwise Implementation tool specifically highlights documented selection, ordering, acceptance testing and storage of new reagents and consumables.
Final Checklist Before Purchase
A final review should bring analytical, quality and supply requirements into one approval record. The laboratory can assign each item to technical, quality or purchasing personnel so that commercial approval is not completed before essential compatibility and documentation questions are closed. Any exception should have a documented risk assessment, responsible approver and defined action before the material is released for use.
The checklist should remain product-specific and should be updated when an assay, analyzer, regulation or supplier arrangement changes. A concise decision table helps prevent omissions while preserving an auditable explanation of why the selected material was accepted.
Checkpoint | Evidence to Review | Acceptance Question |
Intended use | Instructions for use and assay documentation | Does the material match the analyte, method, matrix and clinical application? |
System compatibility | Analyzer and reagent specifications | Is use supported for the exact instrument, reagent and software configuration? |
Assigned values | Lot sheet and certificate | Are values, units and concentration levels clear and applicable? |
Traceability | Traceability statement and reference hierarchy | Is the value linked to the highest available suitable reference? |
Stability | Shelf-life and handling claims | Will the product remain usable through delivery, storage and routine consumption? |
Regulatory status | Market-specific product documentation | Is the product appropriately documented for the destination market? |
Supplier capability | Qualification and distribution records | Can the supplier maintain traceability, temperature control and continuity? |
Receipt verification | Internal acceptance procedure | Can the laboratory verify and release each shipment and new lot before use? |